IASLC

@IASLC

The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer.

Denver, CO
iaslc.org
Vrijeme pridruživanja: srpanj 2009.
1.531 fotografija ili videozapis Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @IASLC

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IASLC

  1. Prikvačeni tweet
    31. sij

    Exciting to see NELSON screening trial results published in . In the attached graphic, our CSO, , provides his perspective on the trial's implications. Watch NELSON investigator, Harry J. de Koning, discuss the trial at :

    , , i još njih 7
    1 reply 26 proslijeđenih tweetova 41 korisnik označava da mu se sviđa
    Poništi
  2. prije 19 sati

    On , it's important to remind everyone that, despite being the most common cancer, it receives insufficient research funding. We're committed to changing that and improving outcomes. Get involved --> .

    16 proslijeđenih tweetova 29 korisnika označava da im se sviđa
    Poništi
  3. proslijedio/la je Tweet
    prije 22 sata

    A must-read at ⁦⁩ : New approaches to small cell lung cancer therapy: from the laboratory to the clinic. A nice summary of updates presented at ⁦⁩ Small Cell Lung Cancer Meeting 2019 👉freely avalable 🙏🙏🙏🙏🙏🙏🙏🙏, tks

    9 proslijeđenih tweetova 20 korisnika označava da im se sviđa
    Poništi
  4. proslijedio/la je Tweet
    prije 23 sata

    To mark have released our position paper on 'Disparities and challenges in access to lung cancer diagnostics and treatment across '. must do more for people impacted by

    15 proslijeđenih tweetova 32 korisnika označavaju da im se sviđa
    Poništi
  5. proslijedio/la je Tweet
    4. velj

    2020: celebrating the millions of patients worldwide whose strength, resilience, hope, & passion for life inspire us every day ❤️

    9 proslijeđenih tweetova 32 korisnika označavaju da im se sviđa
    Poništi
  6. proslijedio/la je Tweet
    3. velj

    📣 : Your chance to network and partner with the leaders in the field. Reduced fees until 5 February 🙌📝✅

    8 proslijeđenih tweetova 10 korisnika označava da im se sviđa
    Poništi
  7. 3. velj

    Thanks to "Team Hope" for fundraising during the Super Bowl challenge on behalf of our foundation, the International Lung Cancer (ILC) Foundation, and early detection research. And thank you to all who donated to help them win a trip to the Taste of the NFL!

    i
    4 proslijeđena tweeta 12 korisnika označava da im se sviđa
    Poništi
  8. proslijedio/la je Tweet
    2. velj

    A massive community effort to put this review together. We hope this is useful for the field. New approaches to small cell lung cancer therapy : from the laboratory to the clinic

    28 proslijeđenih tweetova 74 korisnika označavaju da im se sviđa
    Poništi
  9. proslijedio/la je Tweet
    31. sij

    Register now for the Feb. 28th -AACR- Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Therapeutic Trials! Attend to hear from experts on the importance of assessing tobacco use in clinical trials.

    4 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  10. proslijedio/la je Tweet
    31. sij

    In a new article now available on our site, Chung and colleagues present a pooled analysis of patients from KEYNOTE-028 and KEYNOTE-158 who had received two or more lines of previous therapy for .

    , , i još njih 7
    9 proslijeđenih tweetova 17 korisnika označava da im se sviđa
    Poništi
  11. proslijedio/la je Tweet
    30. sij

    Great to see the discussions following publication y'day. I remember sitting in the plenary at listening to Harry DeKoning first present this data in Toronto. Check out the PC that followed (start at 16.10)

    9 proslijeđenih tweetova 24 korisnika označavaju da im se sviđa
    Poništi
  12. proslijedio/la je Tweet
    30. sij

    Important publication from NELSON study. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial | NEJM

    11 proslijeđenih tweetova 42 korisnika označavaju da im se sviđa
    Poništi
  13. proslijedio/la je Tweet
    29. sij

    Check out the new JTO Clinical and Research Reports journal - now open for submissions -

    7 proslijeđenih tweetova 13 korisnika označava da im se sviđa
    Poništi
  14. proslijedio/la je Tweet
    29. sij

    ASCO and members at practices in 🇧🇷 can now participate in the track

    4 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  15. proslijedio/la je Tweet
    28. sij

    "JTO Research Watch: Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions A Randomized Clinical Trial." Full article:

    11 proslijeđenih tweetova 16 korisnika označava da im se sviđa
    Poništi
  16. 28. sij

    First-of-its-kind technology enhances the visualization of lung cancer tissue and may have the potential to improve outcomes.

    8 proslijeđenih tweetova 19 korisnika označava da im se sviđa
    Poništi
  17. 27. sij

    If you belong to a patient or caregiver organization, you can still submit a grant proposal for the Alliance ILC2 program. But the deadline to apply is Jan. 31! Get funding and help transform patient care around the world.

    5 proslijeđenih tweetova 9 korisnika označava da im se sviđa
    Poništi
  18. proslijedio/la je Tweet
    27. sij

    JTO Research Watch: "An Analysis of E-Cigarette Marketing in New Zealand Tobacco Retail Outlets Prior to Legislative Change."

    3 proslijeđena tweeta 5 korisnika označava da im se sviđa
    Poništi
  19. 24. sij

    The U.S. Surgeon General recently released “Smoking Cessation: A Report of the Surgeon General.” The report is the first in 30 years to focus on smoking cessation.

    3 proslijeđena tweeta 9 korisnika označava da im se sviđa
    Poništi
  20. proslijedio/la je Tweet
    24. sij

    New article by Huber et al. presents updated data from a Phase II randomized study evaluating brigatinib in crizotinib-refractory anaplastic lymphoma kinase–positive . Read the full article -->

    8 proslijeđenih tweetova 16 korisnika označava da im se sviđa
    Poništi

@IASLC još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·